Contrasting Vestis (NYSE:VSTS) & Rejuvel Bio-Sciences (OTCMKTS:NUUU)

Vestis (NYSE:VSTSGet Free Report) and Rejuvel Bio-Sciences (OTCMKTS:NUUUGet Free Report) are both industrial products companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, dividends, earnings, valuation, risk, analyst recommendations and institutional ownership.

Volatility and Risk

Vestis has a beta of 1.17, suggesting that its stock price is 17% more volatile than the S&P 500. Comparatively, Rejuvel Bio-Sciences has a beta of 0.47, suggesting that its stock price is 53% less volatile than the S&P 500.

Profitability

This table compares Vestis and Rejuvel Bio-Sciences’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Vestis 0.75% 9.07% 2.65%
Rejuvel Bio-Sciences N/A N/A N/A

Analyst Recommendations

This is a breakdown of current ratings and target prices for Vestis and Rejuvel Bio-Sciences, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Vestis 1 7 2 0 2.10
Rejuvel Bio-Sciences 0 0 0 0 0.00

Vestis presently has a consensus price target of $16.91, indicating a potential upside of 3.58%. Given Vestis’ stronger consensus rating and higher possible upside, equities research analysts clearly believe Vestis is more favorable than Rejuvel Bio-Sciences.

Valuation and Earnings

This table compares Vestis and Rejuvel Bio-Sciences”s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Vestis $2.81 billion 0.77 $20.97 million $0.16 102.06
Rejuvel Bio-Sciences N/A N/A N/A N/A N/A

Vestis has higher revenue and earnings than Rejuvel Bio-Sciences.

Insider & Institutional Ownership

97.4% of Vestis shares are owned by institutional investors. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Vestis beats Rejuvel Bio-Sciences on 9 of the 9 factors compared between the two stocks.

About Vestis

(Get Free Report)

Vestis Corporation provides uniform rentals and workplace supplies in the United States and Canada. Its products include uniform options, such as shirts, pants, outerwear, gowns, scrubs, high visibility garments, particulate-free garments, and flame-resistant garments, as well as shoes and accessories; and workplace supplies, including managed restroom supply services, first-aid supplies and safety products, floor mats, towels, and linens. The company serves manufacturing, hospitality, retail, food processing, food service, pharmaceuticals, healthcare, automotive, and cleanroom industries. Vestis Corporation was founded in 1936 and is headquartered in Roswell, Georgia.

About Rejuvel Bio-Sciences

(Get Free Report)

Rejuvel Bio-Sciences, Inc., a development stage company, produces, distributes, markets, and sells skin care products worldwide. The company primarily offers skin cream under the Rejuvel brand. It also intends to develop, build, and sell environmental management solutions that use electron particle accelerator technology for the treatment of drinking water, municipal and industrial wastewater, sludge, and produced water from oil and gas fracturing activities. The company was formerly known as Technology Applications International Corporation and changed its name to Rejuvel Bio-Sciences, Inc. in June 2015. Rejuvel Bio-Sciences, Inc. was founded in 2009 and is headquartered in Miami, Florida.

Receive News & Ratings for Vestis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vestis and related companies with MarketBeat.com's FREE daily email newsletter.